Filing Details

Accession Number:
0001127602-18-017517
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-15 16:09:06
Reporting Period:
2018-05-14
Accepted Time:
2018-05-15 16:09:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221496 George Massaro 251 Ballardvale Street
Wilmington MA 01887
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-14 2,004 $0.00 15,055 No 4 A Direct
Common Stock Disposition 2018-05-14 100 $106.05 14,955 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $106.45 14,855 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $106.85 14,755 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $107.08 14,655 No 4 S Direct
Common Stock Disposition 2018-05-14 118 $107.10 14,537 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $107.14 14,437 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $107.48 14,337 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $107.55 14,237 No 4 S Direct
Common Stock Disposition 2018-05-14 200 $107.62 14,037 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $107.67 13,937 No 4 S Direct
Common Stock Disposition 2018-05-14 100 $107.69 13,837 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders.
  2. This sale occurred pursuant to a 10b5-1 Trading Plan.